We have been investigating the roles and implications of eukaryotic elongation factor-2 kinase (eEF-2 kinase, also known as Ca2+/calmodulin-dependent protein kinase III), a critical enzyme that controls protein translation and is up-regulated in glioma and several other types of human cancer [11–13]. This evidence concerns the gene EEF2K and cancer.